Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -228.24%-271.98M | ---- | 194.99%212.09M | ---- | -1.48%-223.27M | ---- | 7.56%-220.02M | ---- | -227.84%-238.02M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -141.79%-112.09M | ---- | --268.21M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -79.82%22.11M | ---- | 651.89%109.58M | ---- | 386.45%14.57M | ---- | -83.69%3M | ---- | --18.37M |
| -Other impairments and provisions | ---- | -79.82%22.11M | ---- | 651.89%109.58M | ---- | 386.45%14.57M | ---- | -83.69%3M | ---- | --18.37M |
| Revaluation surplus: | ---- | ---- | ---- | -1,989.48%-22.09M | ---- | 138.86%1.17M | ---- | ---3.01M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -1,989.48%-22.09M | ---- | 138.86%1.17M | ---- | ---3.01M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | 77.94%-319K | ---- | -36,250.00%-1.45M | ---- | 100.46%4K | ---- | -17,320.00%-871K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---1.45M | ---- | ---- | ---- | ---871K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---319K | ---- | ---- | ---- | --4K | ---- | ---- |
| Depreciation and amortization: | ---- | -23.13%232.72M | ---- | 202.44%302.75M | ---- | -57.27%100.1M | ---- | -64.53%234.28M | ---- | 35.48%660.51M |
| -Amortization of intangible assets | ---- | -24.22%219.1M | ---- | 235.12%289.14M | ---- | -60.33%86.28M | ---- | -66.16%217.47M | ---- | 36.39%642.64M |
| Financial expense | ---- | -349.05%-1.96M | ---- | -61.81%787K | ---- | 186.31%2.06M | ---- | -146.93%-2.39M | ---- | 3,697.01%5.09M |
| Special items | ---- | ---- | ---- | ---- | ---- | 493.80%13.89M | ---- | 116.75%2.34M | ---- | -317.15%-13.96M |
| Operating profit before the change of operating capital | ---- | -115.06%-131.2M | ---- | 1,037.36%871.01M | ---- | -754.19%-92.92M | ---- | -96.71%14.2M | ---- | -36.63%431.11M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -130.24%-27.45M | ---- | -44.80%90.78M | ---- | 159.70%164.47M | ---- | -33.09%-275.49M | ---- | -291.21%-207M |
| Accounts payable increase (decrease) | ---- | -126.51%-10.28M | ---- | 203.82%38.79M | ---- | -134.72%-37.37M | ---- | 667.26%107.61M | ---- | -1,044.77%-18.97M |
| prepayments (increase)decrease | ---- | -80.35%10M | ---- | 30.58%50.89M | ---- | 116.51%38.97M | ---- | -1.62%-236.02M | ---- | -6,337.44%-232.26M |
| Special items for working capital changes | ---- | 96.95%-20.31M | ---- | -456.90%-665.56M | ---- | -52.07%-119.51M | ---- | 84.32%-78.59M | ---- | 27.48%-501.13M |
| Cash from business operations | 52.45%-90.16M | -146.45%-179.24M | -212.49%-189.63M | 932.47%385.91M | 437.25%168.58M | 90.10%-46.36M | 108.73%31.38M | 11.35%-468.28M | -357.35%-359.63M | -650.64%-528.25M |
| Other taxs | 85.27%-1.13M | 51.55%-10.46M | -106.58%-7.66M | ---21.6M | ---3.71M | ---- | ---- | 97.17%-1.26M | 98.93%-462K | -97.69%-44.33M |
| Net cash from operations | 53.73%-91.29M | -152.07%-189.7M | -219.67%-197.3M | 885.89%364.31M | 425.42%164.87M | 90.13%-46.36M | 108.71%31.38M | 18.00%-469.54M | -195.61%-360.09M | -878.90%-572.58M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -71.66%259K | -26.88%1.42M | 444.05%914K | -4.00%1.95M | -91.53%168K | 694.90%2.03M | 1,131.68%1.98M | -84.58%255K | -78.15%161K | -45.52%1.65M |
| Sale of fixed assets | ---- | ---- | ---- | --331K | ---- | ---- | ---- | --3K | --3K | ---- |
| Purchase of fixed assets | -5.26%-20K | 97.44%-35K | 48.65%-19K | -850.69%-1.37M | 60.22%-37K | 2.04%-144K | -63.16%-93K | 33.18%-147K | 66.07%-57K | 93.22%-220K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---41K |
| Recovery of cash from investments | ---- | ---- | ---- | 918.53%22.15M | ---- | -72.26%2.18M | --2.17M | --7.84M | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.24M | ---- | ---- |
| Net cash from investment operations | -73.30%239K | -93.98%1.39M | 583.21%895K | 468.28%23.06M | -96.78%131K | 1,499.31%4.06M | 3,698.13%4.06M | -120.82%-290K | -81.20%107K | 3,765.79%1.39M |
| Net cash before financing | 53.64%-91.05M | -148.61%-188.32M | -219.03%-196.4M | 1,015.80%387.37M | 365.55%165M | 91.00%-42.3M | 109.85%35.44M | 17.74%-469.83M | -196.91%-359.98M | -877.41%-571.18M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 212.52%43.34M | ---- | -89.00%13.87M | 226.59%13.87M | 54.77%126.11M | -93.57%4.25M | -9.51%81.48M | 54.09%66.03M | 34.87%90.04M |
| Refund | ---13.98M | ---- | ---- | 3.98%-119.89M | 45.88%-53.34M | -590.07%-124.86M | ---98.56M | 80.51%-18.09M | ---- | 77.21%-92.85M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -8.58%468.98M | --468.98M | 31.35%513.01M |
| Interest paid - financing | -58.66%-522K | 93.99%-542K | 70.65%-329K | -459.88%-9.01M | -25.53%-1.12M | 88.53%-1.61M | 91.15%-893K | -944.72%-14.04M | -1,333.95%-10.1M | 83.82%-1.34M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.84%-61.66M | ---49.68M | -7,062.41%-39.82M |
| Net cash from financing operations | -197.71%-20.24M | 122.30%28.6M | 85.50%-6.8M | -863.15%-128.25M | 54.06%-46.88M | -103.02%-13.32M | -121.82%-102.04M | -2.90%440.57M | 1,265.99%467.68M | 1,529.43%453.73M |
| Effect of rate | 143.27%2.04M | -108.78%-5.45M | 62.04%-4.72M | 57.37%-2.61M | -509.20%-12.45M | -346.48%-6.12M | -180.40%-2.04M | -26.71%2.48M | 136.47%2.54M | 192.97%3.39M |
| Net Cash | 45.23%-111.29M | -161.64%-159.71M | -272.01%-203.2M | 565.92%259.12M | 277.38%118.13M | -90.11%-55.62M | -161.84%-66.6M | 75.09%-29.25M | 223.77%107.69M | -215.92%-117.45M |
| Begining period cash | -53.25%144.99M | 478.26%310.15M | 478.26%310.15M | -53.51%53.63M | -53.51%53.63M | -18.83%115.37M | -18.83%115.37M | -44.52%142.14M | -44.52%142.14M | 61.61%256.2M |
| Cash at the end | -65.04%35.74M | -53.25%144.99M | -35.84%102.22M | 478.26%310.15M | 240.95%159.32M | -53.51%53.63M | -81.48%46.73M | -18.83%115.37M | 55.57%252.37M | -44.52%142.14M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.